For instance, serious incidents of arterial thrombosis may develop as a result of therapy failure of clopidogrel, a pro-drug platelet inhibitor, which requires CYP2C19 metabolism to be converted to its active drug metabolite. This evidence concerns the gene CYP2C19 and Arterial thrombosis.